Coverage
-
February 04, 2013
Matrixx Initiatives Inc. will dole out $4.5 million to settle a suit claiming its failure to alert the government to complaints that its Zicam cold remedy products allegedly caused users to lose their sense of smell sparked a free fall in its stock price, according to a motion filed Thursday.
2 other articles on this case.
View all »